Chinese Perspectives on Clinical Efficacy and Safety of Alectinib in Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s185115
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2019
Authors
Publisher
Informa UK Limited